The importance of patient perspective in drug surveillance systems;Die Bedeutung der Patientensicht bei der Erfassung der Sicherheit neuer Medikamente

Zeitschrift fur Rheumatologie

Volumn 69, Issue 9, 2010, Pages 795-802

  Gawert L ^a   Hierse, F ^a   Zink, A ^a,b   Strangfeld, A ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adverse drug reaction; Drug surveillance; Patient reports; RABBIT register

Indexed keywords

ADULT; ADVERSE DRUG REACTION; ALOPECIA; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DOCTOR PATIENT RELATION; DRUG SURVEILLANCE PROGRAM; FATIGUE; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE REACTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NAUSEA; OBSERVATIONAL STUDY; PHYSICIAN; REGISTER; RHEUMATOID ARTHRITIS; RHEUMATOLOGY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; DRUG TOXICITY; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT PARTICIPATION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649669815     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-010-0642-0     Document Type: Article

References (20)

1. Aagaard L, Nielsen LH, Hansen EH (2009) Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 32:1067-1074
2. Backstrom M, Mjorndal T, Dahlqvist R, Nordkvist-Olsson T (2000) Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol 56:729-732
3. Basch E, Iasonos A, McDonough T et al. (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7:903-909
4. Belton KJ (1997) Attitude survey of adverse drugreaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol 52:423-427
5. Bent S, Padula A, Avins AL (2006) Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med 144:257-261 (Pubitemid 46768208)
6. Blenkinsopp A, Wilkie P, Wang M, Routledge PA (2007) Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 63:148-156
7. Langen J de, Hunsel F van, Passier A et al (2008) Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 31:515-524
8. Eland IA, Belton KJ, Grootheest AC van et al (1999) Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 48:623-627
9. Gäwert L, Hierse F, Zink A, Strangfeld A (2010) How well do patient reports reflect adverse drug reactions reported by rheumatologists? Agreement of physician-and patient-reported adverse events in patients with rheumatoid arthritis observed in the German biologics register. Rheumatology [Epub ahead of print Sep. 25]
10. Hasford J, Goettler M, Munter KH, Muller-Oerlinghausen B (2002) Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 55:945-950
11. Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions: a systematic review. Drug Saf 29:385-396
12. Heeley E, Riley J, Layton D et al (2001) Prescriptionevent monitoring and reporting of adverse drug reactions. Lancet 358:1872-1873
13. Jarernsiripornkul N, Kakaew W, Loalukkana W, Krska J (2009) Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. Pharmacoepidemiol Drug Saf 18:240-245
14. Martin RM, Kapoor KV, Wilton LV, Mann RD (1998) Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study. BMJ 317:119-120
15. MedDRA Maintenance and Support Services Organization (2010) Northrop Grumman Corporation, McLean, Virginia, USA. http://www.meddramsso.com (Zugriff am 01.09.2010)
16. Pollard LC, Choy EH, Gonzalez J et al (2006) Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 45:885-889
17. Prevots DR, Sutter RW, Strebel PM et al (1994) Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med 148:479-485
18. Grootheest K van, Jong-van den Berg L de (2004) Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf 3:363-368
19. Grootheest K van, Jong-van den Berg L de (2004) Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf 3:363-368
20. Williams D, Feely J (1999) Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci 168:257-261